Biotest Aktiengesellschaft reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 684.6 million compared to EUR 516.1 million a year ago. Net income was EUR 127 million compared to net loss of EUR 31.7 million a year ago.

Basic earnings per share from continuing operations was EUR 3.2 compared to basic loss per share from continuing operations of EUR 0.81 a year ago.